4
Changes in Ownership
Dolby Laboratories, Inc. Filed Acc 0001209191-19-058204
EVP & Chief Financial Officer sold 32,185 shares at an average $69.21 ($2,227,485)
- EVP & Chief Financial Officer acquired 32,185 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CHEW LEWIS EVP & Chief Financial Officer | 2019-11-25 | Option exercise | +30,000 | $30.49 | $914,700 | 121,946 | D: show line 1 in the form |
| CHEW LEWIS EVP & Chief Financial Officer | 2019-11-25 | Sale | −30,000 | $69.22 | $2,076,585 | 91,946 | D: show line 2 in the form |
| CHEW LEWIS EVP & Chief Financial Officer | 2019-11-25 | Option exercise | +2,185 | $37.96 | $82,943 | 94,131 | D: show line 3 in the form |
| CHEW LEWIS EVP & Chief Financial Officer | 2019-11-25 | Sale | −2,185 | $69.06 | $150,900 | 91,946 | D: show line 4 in the form |
| Open-market sales · 32,185 sh · avg $69.21 · $2,227,485 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CHEW LEWIS EVP & Chief Financial Officer | 2019-11-25 | Option exercise · Employee Stock Option (right to buy) | −30,000 | 4,400 | D: show line 5 in the form | ||
| CHEW LEWIS EVP & Chief Financial Officer | 2019-11-25 | Option exercise · Employee Stock Option (right to buy) | −2,185 | 0 | D: show line 6 in the form |
Loading xslF345X03/doc4.xml…